fda compounding glp-1 warning letters october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Dose:5.00 mg Age_Range: 18-24 People often don't understand

fda compounding glp-1 warning letters october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Dose:5.00 mg Age_Range: 18-24 People often don't understand

People often don't understand what is likely to happen when they stop taking the popular GLP-1 medications. A recent email ad from a telehealth company selling weight-loss medications features tennis-superstar Serena Williams. “

DOI.org (Crossref) , Mehrtash, Farhad, et al

Age_Range: 18-24

Dose:5.00 mg

The class carries a boxed warning for thyroid C-cell tumor risk seen in rodent studies, plus rare risks of pancreatitis, gallbladder disease, and kidney injury with dehydration